These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9410826)

  • 1. Proceedings of the Workshop on Application of Biomarkers to Cancer Epidemiology. Lyon, France, 20-23 February 1996.
    IARC Sci Publ; 1997; (142):1-318. PubMed ID: 9410826
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of biomarkers in cancer epidemiology. Workshop report.
    IARC Sci Publ; 1997; (142):1-18. PubMed ID: 9354907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic oxidative stress and cancer: mechanisms, biomarkers and prevention. Proceedings of an international conference. October 23-26, 2005. Heidelberg, Germany.
    Biol Chem; 2006 Apr; 387(4):347-483. PubMed ID: 16606330
    [No Abstract]   [Full Text] [Related]  

  • 4. Workshop summary: roles of the TNF family in normal development and cancer.
    Ruddle NH
    Adv Exp Med Biol; 2011; 691():3-4. PubMed ID: 21153304
    [No Abstract]   [Full Text] [Related]  

  • 5. The Implications of "Random Chance" in Cancer Genesis: Why Stochastic Can Be a Dirty Word.
    Meisenberg BR
    JAMA Oncol; 2015 Aug; 1(5):575-6. PubMed ID: 26181509
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers: a framework driving advances in oncology.
    Nicolini A
    Biomark Med; 2015; 9(4):303-6. PubMed ID: 25808434
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass spectrometric DNA adduct quantification by multiple reaction monitoring and its future use for the molecular epidemiology of cancer.
    Monien BH
    Adv Exp Med Biol; 2014; 806():383-97. PubMed ID: 24952193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euro-Immunoanalyse '93. Proceedings. Lyon, France, 3-5 February 1993.
    Nucl Med Biol; 1994 Apr; 21(3):287-572. PubMed ID: 9296761
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular Markers in the Diagnosis and Treatment of Cancer.
    Gokden M; Ariza A; Arnaoutakis K
    Biomed Res Int; 2015; 2015():105217. PubMed ID: 26451364
    [No Abstract]   [Full Text] [Related]  

  • 10. Present and future of cancer biomarkers.
    Diamandis EP
    Clin Chem Lab Med; 2014 Jun; 52(6):791-4. PubMed ID: 24803613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomonitoring and Susceptibility Markers in Human Cancer: Applications in Molecular Epidemiology and Risk Assessment. Proceedings of a symposium. Kailua-Kona, Hawaii, October 16-November 1, 1991.
    Environ Health Perspect; 1992 Nov; 98():1-219. PubMed ID: 1362536
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers.
    Ueda K
    Proteomics Clin Appl; 2013 Oct; 7(9-10):607-17. PubMed ID: 23640819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and prognostic cancer biomarkers revisited.
    Pritzker KP
    Expert Rev Mol Diagn; 2015; 15(8):971-4. PubMed ID: 26134385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of mass spectrometry imaging in tumor diagnosis and treatment].
    Mao X; Sun J; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):285-8. PubMed ID: 24915826
    [No Abstract]   [Full Text] [Related]  

  • 15. Transformation assay of established cell lines: mechanisms and application. Proceedings of a workshop organized by IARC in collaboration with the US National Cancer Institute and the US Environmental Protection Agency. Lyon, 15-17 February 1984.
    IARC Sci Publ; 1985; 67():1-225. PubMed ID: 3830888
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical translational potential of p53-related alterations as cancer biomarkers.
    Xiao M; Wang X; Chen W
    Histol Histopathol; 2015 Oct; 30(10):1171-83. PubMed ID: 26069201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we detect cancer earlier? A Harvard team's breakthrough may make it possible.
    Harv Health Lett; 2013 Feb; 38(4):1, 7. PubMed ID: 23841163
    [No Abstract]   [Full Text] [Related]  

  • 18. Value of calretinin immunostaining in diagnostic pathology: a review and update.
    Ordóñez NG
    Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):401-15. PubMed ID: 24185118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It is well established that affected intracellular signaling is associated with carcinogenesis, cancer progression and tumor sensitivity to currently existing therapeutic approaches.
    Skvortsova I
    Semin Cancer Biol; 2015 Apr; 31():1-2. PubMed ID: 25559282
    [No Abstract]   [Full Text] [Related]  

  • 20. Pesticides and cancer: insights into toxicoproteomic-based findings.
    George J; Shukla Y
    J Proteomics; 2011 Nov; 74(12):2713-22. PubMed ID: 21989265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.